Login to Your Account

Clinic Roundup

Friday, June 22, 2012

• Medigene AG, of Martinsried, Germany, said that a clinical formulation trial with RhuDex achieved positive results and that the further clinical development of the drug for the treatment of autoimmune diseases will continue with an optimized oral formulation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription